Assessment of Probe Based Confocal Laser Endo-microscopy for In-vivo Diagnosis of Peripheral Lung Nodules and Masses.
NODIVEM
2 other identifiers
interventional
120
1 country
3
Brief Summary
Solitary pulmonary nodule has become a major challenge in respiratory clinical practice. According to published guidelines, their management often requires close CT follow up, PET CT and invasive procedures to obtain a definite histology. In this context, innovative endoscopic techniques refered as navigational bronchoscopy have proved to be efficient, for the localization and sampling of peripheral lung nodules. However, these techniques are unable to differentiate malignant lesions from benign ones, in-vivo, in real time. Confocal endo-microscopy (CELLVIZIO) of the distal lung - also refered as distal lung probe based confocal laser endo-microscopy or alveolar lung endo-microscopy - allows in-vivo imaging of the distal lung structures in real time. This prospective trial we will assess confocal endoscopy as a tool to localize the peripheral lung nodules and to differentiate benign from tumoral lesions. Objective(s)
- 1.To demonstrate that confocal endo-microscopy is not inferior to navigational endoscopy for the localisation of peripheral lung nodule
- 2.To demonstrate that confocal endoscopy can differentiate benign from malignant tumors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2012
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 29, 2013
CompletedFirst Posted
Study publicly available on registry
August 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedApril 16, 2026
April 1, 2026
3.6 years
July 29, 2013
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of confocal imaging (solid pattern) for the diagnostic of the pulmonary nodule
Confocal imaging will be considered as "positive" when both * a solid pattern is displayed * a diagnostic biopsy is obtained at the site of confocal imaging
six months after the procedure
Study Arms (1)
confocal endo-microscopy
EXPERIMENTALconfocal endo-microscopy : CELLVIZIO endo-microscopy procedure is performed in every patient using the same extended working channel as for navigational bronchoscopy.
Interventions
The intervention consists of the use of confocal endo-microscopy using the CELLVIZIO device and either the 1 mm CELLVIZIO miniprobe (ALVEOFLEX) or the 0.6 mm CELLVIZIO miniprobe (CHOLANGIOFLEX), during a navigational bronchoscopy procedure for the diagnostic of peripheral nodule. In this study, the navigational device - either radial endobronchial ultrasound (EBUS) or electromagnetic navigation (EMN) - will be moved to another location if the CELLVIZIO displays a non solid pattern, indicating that the nodule may not have been reached during the procedure. Three attempts of EBUS or EMN are allowed until the CELLVIZIO shows a solid pattern.
Eligibility Criteria
You may qualify if:
- Patients with a peripheral lung nodule accessible by navigational bronchoscopy and CELLVIZIO according to Investigator evaluation of the CT scan.
- years old or more.
- Affiliation to french social security insurance.
- Signed informed consent for the procedure.
You may not qualify if:
- Severe respiratory insufficiency that will not allow the bronchoscopy procedure
- Uncorrected bleeding disorders
- History of pneumonectomy or exploration controlateral to a non functional lung,
- Pregnant or breast feeding woman, or person not authorized to participate to a clinical trial according to L1121-6 et L1121-8 of French Code of Public Health, concurrent participation to another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UHRouen
Rouen, 76031, France
CHU Saint Etienne
Saint-Etienne, 42055, France
CHU Toulouse
Toulouse, 31059, France
Related Publications (2)
Hassan T, Thiberville L, Hermant C, Lachkar S, Piton N, Guisier F, Salaun M. Assessing the feasibility of confocal laser endomicroscopy in solitary pulmonary nodules for different part of the lungs, using either 0.6 or 1.4 mm probes. PLoS One. 2017 Dec 21;12(12):e0189846. doi: 10.1371/journal.pone.0189846. eCollection 2017.
PMID: 29267317RESULTHassan T, Piton N, Lachkar S, Salaun M, Thiberville L. A Novel Method for In Vivo Imaging of Solitary Lung Nodules Using Navigational Bronchoscopy and Confocal Laser Microendoscopy. Lung. 2015 Oct;193(5):773-8. doi: 10.1007/s00408-015-9769-8. Epub 2015 Jul 28.
PMID: 26216723RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luc C Thiberville, MD
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2013
First Posted
August 29, 2013
Study Start
May 1, 2012
Primary Completion
December 1, 2015
Study Completion
June 1, 2016
Last Updated
April 16, 2026
Record last verified: 2026-04